Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

1 – Graph showing the percentage of patients with rheumatoid factor or positive or negative anti-CCP antibody, among SSc patients without arthritis, SSc with arthritis, and

Objective: To determine the prevalence of depressive and anxiety symptoms in patients with rheumatoid arthritis (a chronic inflammatory disease) in comparison to a

From the development of this study, it was possible to identify relevant features and aspects to be highlighted at the time of care and health care of patients using

As observed in studies with infliximab, NURC patients refractory to conventional therapy and treated with adalimumab had a better clinical response and improved clinical

The authors report the case of a 19-year-old male patient with Crohn’s disease treated with infliximab and azathioprine, with sustained clinical remission; in the course of

Improvement in work place and household productivity for pa- tients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations

Figure 1 - Peripheral red blood cells ( a ), haemoglobin ( b ), hematocrit ( c ) levels and erythrocyte sedimentation rate ( d ) in patients with rheumatoid arthritis (RA) treated

Additional secondary outcomes also demonstrated higher rates of steroid-free remission in the VEDO patients, and higher remission and response rates in patients without